![]() |
Factsheet as on June 30, 2025 |
To generate consistent returns by investing in equity or fixed income securities of pharma and other associated companies.
1 Year | 2 Years | 3 Years | 5 Years | |
Scheme (%) | 16.23 | 27.93 | 25.75 | 22.41 |
Nifty 500 (%) | 4.66 | 19.86 | 20.81 | 22.74 |
Company Name | % of Assets |
Sun Pharmaceutical Industries Ltd. | 12.2 |
Divi Laboratories Ltd. | 8.5 |
Lupin Ltd. | 6.1 |
Cipla Ltd. | 5.6 |
Apollo Hospitals Enterprise Ltd. | 5.5 |
Dr Reddys Laboratories Ltd. | 5.2 |
Medplus Health Services Ltd. | 3.8 |
Glaxo Smithkline Pharmaceuticals Ltd. | 3.6 |
Narayana Hrudayalaya Ltd. | 3.6 |
Vijaya Diagnostic Centre Ltd. | 3.3 |
Standard Deviation | 14.75 |
Information Ratio | 0.11 |
Beta | 0.75 |
Sharpe Ratio | 0.34 |
Kotak Mahindra Bank Limited, AMFI Registered Mutual Fund Distributor, ARN 1390
Kotak Mahindra Bank Limited, AMFI Registered Mutual Fund Distributor, ARN 1390